PRS9 THE COST-EFFECTIVENESS OF TARGETED PRESCRIBING OF ANTIMICROBIALS IN CANADA FOR COMMUNITY-ACQUIRED PNEUMONIA IN AN ERA OF ANTIMICROBIAL RESISTANCE
Abstract
Authors
L Moore M Martin S Quilici DE Low R Grossman A Kureishi M Kubin B Jaszewski M Rebeira